SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

H.C. Wainwright Initiates Coverage On Immunic with Buy Rating, Announces Price Target of $45

H.C. Wainwright analyst Raghuram Selvaraju initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and announces Price Target of $45.

Benzinga · 05/11/2020 11:37

H.C. Wainwright analyst Raghuram Selvaraju initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and announces Price Target of $45.